Sounds like Avigan (favipiravir) trial is done as expected. I'd like to see the final data first, but this will be a good addition. It's cheap ($100~150/person) & should be widely available, as it's already made in Japan & China (& India & Russia, as I understand).
It's oral & much much cheaper than remdesivir (IV, $2~3k) & much cheaper.
Major downside is its teratogenicity (causes birth defects), but that shouldn't be an issue for the seniors that are hit the hardest by Covid.
Fujifilm vs. Kodak continues.
It's official.
fujifilm.com/news/n200923.h…
cc:@NickytaLeb
Fujifilm to apply for approval next month, approval possible by the end of year.
(it is already approved for use w/ stricter conditions, so no big rush in reality).
nikkei.com/article/DGXMZO…
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.